Dennis P. Reilly Net Worth

The estimated Net Worth of Dennis Reilly is at least $981 Thousand dollars as of 13 October 2021. Mr Reilly owns over 58,824 units of Agile Therapeutics Inc stock worth over $430,546 and over the last 5 years he sold AGRX stock worth over $0. In addition, he makes $550,761 as Sr. VP & CFO at Agile Therapeutics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr Reilly AGRX stock SEC Form 4 insiders trading

Mr has made over 6 trades of the Agile Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he bought 58,824 units of AGRX stock worth $88,824 on 13 October 2021.

The largest trade he's ever made was buying 75,000 units of Agile Therapeutics Inc stock on 4 March 2020 worth over $174,750. On average, Mr trades about 23,893 units every 53 days since 2019. As of 13 October 2021 he still owns at least 285,130 units of Agile Therapeutics Inc stock.

You can see the complete history of Mr Reilly stock trades at the bottom of the page.

Mr. Dennis P. Reilly biography

Dennis P. Reilly is the Sr. VP & CFO at Agile Therapeutics Inc.

What is the salary of Mr Reilly?

As the Sr. VP & CFO of Agile Therapeutics Inc, the total compensation of Mr Reilly at Agile Therapeutics Inc is $550,761. There are 6 executives at Agile Therapeutics Inc getting paid more, with Alfred Altomari having the highest compensation of $1,301,370.

How old is Mr Reilly?

Mr Reilly is 62, he's been the Sr. VP & CFO of Agile Therapeutics Inc since . There are 6 older and 10 younger executives at Agile Therapeutics Inc. The oldest executive at Agile Therapeutics Inc is Ajit Shetty, 73, who is the Independent Director.

What's Mr Reilly's mailing address?

Dennis's mailing address filed with the SEC is 101, Poor Farm Road, Princeton, Mercer County, New Jersey, 08540, United States.

Insiders trading at Agile Therapeutics Inc

Over the last 10 years, insiders at Agile Therapeutics Inc have traded over $2,369,944 worth of Agile Therapeutics Inc stock and bought 24,967,253 units worth $79,522,957 . The most active insiders traders include Advisors Llcperceptive Life..., Ab Investor, and Capital Iii Llc Care Capita.... On average, Agile Therapeutics Inc executives and independent directors trade stock every 69 days with the average trade being worth of $1,032,678. The most recent stock trade was executed by Alfred Altomari on 26 August 2022, trading 50,000 units of AGRX stock currently worth $22,500.

What does Agile Therapeutics Inc do?

agile therapeutics is a forward-thinking women's healthcare company dedicated to fulfilling the unmet health needs of today's women. our product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. our lead product candidate, twirla®, (ethinyl estradiol and levonorgestrel transdermal system), also known as ag200-15, is a once-weekly prescription contraceptive patch that recently completed phase 3 trials. twirla is based on our proprietary transdermal patch technology, called skinfusion®, which is designed to provide advantages over currently available patches and is intended to optimize patch adhesion and patient wearability. for more information, please visit the company website at www.agiletherapeutics.com. connect with us on twitter at @agilether.

Complete history of Mr Reilly stock trades at Agile Therapeutics Inc

Agile Therapeutics Inc executives and stock owners

Agile Therapeutics Inc executives and other stock owners filed with the SEC include:

• Alfred Altomari,
  Chairman of the Board, Chief Executive Officer
• Alfred F. Altomari,
  Chairman & CEO
• Geoffrey Gilmore,
  Senior Vice President, General Counsel, Corporate Secretary
• Geoffrey P. Gilmore,
  Sr. VP, Gen. Counsel & Corp. Sec.
• Dr. Paul Korner M.B.A., M.D.,
  Sr. VP & Chief Medical Officer
• Robert Conway,
  Senior Vice President and Chief Supply Chain Officer
• Dennis P. Reilly,
  Sr. VP & CFO
• John Hubbard,
  Independent Director
• James Tursi,
  Independent Director
• Seth Fischer,
  Lead Independent Director
• Ajit Shetty,
  Independent Director
• Sharon Barbari,
  Independent Director
• Sandra Carson,
  Director
• Paul Korner,
  Chief Medical Officer
• Dennis Reilly,
  Chief Financial Officer, Senior Vice President
• Dr. Kathryn MacFarlane Pharm.D.,
  Advisor
• Robert G. Conway M.E.,
  Sr. VP & Chief Supply Chain Officer
• Joseph D'Urso,
  Controller
• Dr. Paul Korner,
  Sr. VP & Chief Medical Officer
• Dr. Elizabeth Ijeoma Onyemelukwe Garner M.D., M.P.H.,
  Consultant
• Robert G. Conway,
  Sr. VP & Chief Supply Chain Officer
• Amy Welsh,
  VP of Marketing
• Matthew Riley,
  Head of Investor Relations & Corp. Communications
• Jason Butch,
  VP & Chief Accounting Officer
• Katie Mac Farlane,
  Chief Commercial Officer
• Scott M Coiante,
  Chief Financial Officer
• Karen Hong,
  Director
• Renee Selman,
  Chief Commercial Officer
• Jay Schreiber Alain Pro Que...,
  
• William Mckee,
  Director
• Abhijeet J Lele,
  Director
• Amy Welsh,
  Chief Commercial Officer
• Capital Iii Llc Care Capita...,
  
• Elizabeth Garner,
  Sr. VP & Chief Medical Officer
• Advisors Llcperceptive Life...,
  
• Ab Investor,
  10% owner
• Andrew N Schiff,
  Director
• Josephine Torrente,
  Director